{
  "id": "cluster_2_doc2",
  "content": "Research protocol memo from Colorado Neurodegenerative Institute detailing participation criteria for study CNI-228 (Lewy spectrum disorders). Includes Gerald Kovac's screening results showing unusual treatment response pattern to cholinesterase inhibitors. Study coordinator: Lydia Marnell (lydia.marnell@cni-research.co), IRB approval expires 10/15/2025.",
  "metadata": {
    "format": "research_note"
  }
}